Next Article in Journal
Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms
Next Article in Special Issue
Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient
Previous Article in Journal
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
Previous Article in Special Issue
Chemotherapeutic Interventions Against Tuberculosis
Article Menu

Export Article

Pharmaceuticals 2012, 5(8), 882-889; doi:10.3390/ph5080882
Open AccessArticle

Notes on Article Versions

Action Date Notes Link
article html file updated 24 January 2013 00:25 CET Original file -
article html file updated 27 January 2013 03:13 CET Update -
article html file updated 29 January 2013 06:04 CET Update -
article html file updated 6 February 2013 09:49 CET Update -
article html file updated 7 February 2013 05:32 CET Update -
article html file updated 7 February 2013 14:29 CET Update -
article xml file uploaded 6 August 2013 16:06 CEST Original file http://www.mdpi.com/1424-8247/5/8/882/xml
article html file updated 6 August 2013 16:07 CEST Update -
article html file updated 17 June 2015 01:47 CEST Update http://www.mdpi.com/1424-8247/5/8/882/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top